Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
Vegetarians, older adults, and those with absorption issues are at higher risk
BPC-157 (Naturally Occuring Acetylated & Amidated Form of BPC-157) 500 mcg Other Ingredients: Microcrystalline Cellulose, Delayed Released Veggie Capsule
She is not only a certified practitioner but also a mentor and proctor in this field
Research Institutions and Academic Studies ResearchGate - Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease: Mentions key researchers and institutions
For people without a deficiency, benefits may be subtle or minimal